Fundamentals Datasheet and Stock Analysis

Profile
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)

Loading...

Activity Data Not Available

Company Information

Non-Executive Director: John Goddard  Non-Executive Chairman: David Robert Norwood  Chief Financial Officer and Senior Vice President: Chris Hill  

Analysis
Composite Ranking: 
Historic EPS Ranking: 
Forecast EPS Ranking: 
Price Relative Strength: 
Industry Strength: 
SMR Ranking: 
ROCE Ranking: 
Accumulation/Dist: 
Mkt Accumulation/Dist: 
Unbroken Annual EPS: 
Unbroken Interim EPS: 
PEG Current Ranking: 
PEG Forecast Ranking: 
PE Current Ranking: 
PE Forecast Ranking: 
Margin Current Ranking: 
Margin Forecast Ranking: 
Chart
Add Indicator




loading




Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Fundamentals
20112012201320142015201620172018E2019E
Day/Month31/1231/1231/1231/1231/1231/1231/1231/1231/12
Revenue£m0.280.471.030.700.750.000.00£m0.000.00
Operating Profit/(loss)£m(0.94)(0.82)(1.56)(3.50)(3.97)(0.48)(0.62)£m0.000.00
Profit Before Tax£m(0.94)(0.82)(1.54)(3.46)(3.88)(0.35)(0.52)£m0.000.00
Profit After Tax£m(0.93)(0.78)(1.49)(2.86)(3.11)(0.35)(0.52)£m0.000.00
Profit After Tax (from discontinued operations)£m0.000.000.000.000.00(1.04)(1.53)£m0.000.00
Overall Profit for the Period£m(0.93)(0.78)(1.49)(2.86)(3.11)(1.38)(2.06)£m0.000.00
EPS Growth%0.000.000.000.000.000.000.00%0.000.00
Earnings Per Sharep(0.19)(0.13)(0.17)(0.29)(0.28)(0.03)(0.04)p0.000.00
Op. Cash Flow P/Sp(0.09)0.42(1.83)(1.50)(1.63)0.97(1.51)£0.000.00
Cash Flow P/S Grth%0.000.000.000.000.000.000.00%0.000.00
Net Cash Flow P/Sp0.000.000.000.000.000.000.00£0.000.00
Capital Exp P/S£0.000.000.000.000.000.000.00£0.000.00
Tax Rate%0.000.000.000.000.000.000.00%0.000.00
P/E Ratiox0.000.000.000.000.000.000.00x0.000.00
P/E Growth£0.000.000.000.000.000.000.00£0.000.00
Turnover Per Share£0.030.050.000.000.000.000.00£0.000.00
Pre-Tax Profit / Share£(0.09)(0.08)0.000.000.000.000.00£0.000.00
Operating Margin%0.000.00(151.41)(495.89)(529.33)0.000.00%0.000.00
ROCE%0.00(12.90)(52.71)(23.50)(11.98)10.86(136.69)%0.000.00
ROE%0.00(9.14)(39.12)(52.55)(76.30)6.420.00%0.000.00
Mkt Cap£m15.3725.3245.5141.2955.7618.9918.08£m0.000.00
Dividend Per Sharep0.000.000.000.000.000.000.00p0.000.00
DPS Growth%0.000.000.000.000.000.000.00%0.000.00
Dividend Yield%0.000.000.000.000.000.000.00%0.000.00
Dividend Coverx0.000.000.000.000.000.000.00x0.000.00
Shareholder Funds£m1.252.399.907.3223.7922.5619.01£m0.000.00
Net Borrowings£m(1.11)(2.22)(9.94)(6.71)(13.06)(16.88)(19.23)£m0.000.00
Net Assets£m1.252.399.907.3223.7922.5619.01£m0.000.00
Net Assets P/S£0.000.000.000.000.000.000.00£0.000.00
Financials
Latest Forecast
Div Yield0.0%0.0%
Div Cover0.0%0.0%
Op Margin0.0%0.0%
ROCE0.0%
Director Deals
Traded Action Notifier Price Amount Value
25-Mar-14BuyDavid Robert Norwood4.30p1,000,000£43,000
02-Nov-11PlacingDavid Robert Norwood1.00p10,000,000£100,000
02-Nov-11PlacingMarcelo Bravo1.00p2,500,000£25,000
  Rows per page
Shareholders
1,206m    Major: 64%    Director: 9%
Notifier Holding Value
David Robert Norwood105,938,633£1,589,079.50
  Rows per page
Gearing & Cover
News
News Title Date Time Source
Result of AGM and Notice of Cancellation08-May-1812:13RNS
Suspension of trading on AIM04-May-1807:00RNS
Proposed Cancellation of Admission06-Apr-1807:00RNS
Final Results06-Apr-1807:00RNS
Strategy update27-Feb-1807:00RNS
Completion of Demerger21-Dec-1710:00RNS
Confirmation of Capital Reductions19-Dec-1715:50RNS
Subdivision of Capital04-Dec-1714:14RNS
FDA Advice on OXPzero Ibuprofen OTC Opportunity29-Nov-1707:00RNS
Result of General Meeting27-Nov-1711:55RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change

No data

  Rows per page
Notes

This functionality requires you to login

Click here to login
Or register for a new account